About Veracyte, Inc

Veracyte is pioneering molecular cytology; we are dedicated to helping people avoid unnecessary invasive procedures just to get a diagnosis and to reducing healthcare costs at the same time. We use rigorous science to unlock genomic answers from tiny numbers of cells obtained through minimally invasive methods before surgery is needed. We launched our first product the Afirma® Thyroid FNA Analysis, with a genomic test at its core in record time and have already helped save thousands of patients from unnecessary surgery due to ambiguous thyroid nodule biopsy results.

Our genomic test is offered by hundreds of physicians around the country, is covered by Medicare and private payers, and is clinically validated, including in a multicenter study published in the New England Journal of Medicine. We launched our second genomic test in the lung cancer space in 2015, and are also developing a second product in pulmonology, targeting interstitial lung diseases.

+ more

What employees say

“I am doing something challenging and am supported.”
“My bosses are people I respect professionally AND personally. I feel that my contributions are valued and impacts the company for good.”
“The culture is a healthy mix of fun and work. I get the feeling from the majority of the people that they are happy to be here and take pride in their work.”
“Their ability to work hard but also have a good time at the same time.”
Where to find Veracyte, Inc